{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T01:31:42Z","timestamp":1775266302775,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T00:00:00Z","timestamp":1683849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.bioorg.2023.106608","type":"journal-article","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T20:55:55Z","timestamp":1683924955000},"page":"106608","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Thalidomide derivatives as nanomolar human neutrophil elastase inhibitors: Rational design, synthesis, antiproliferative activity and mechanism of action"],"prefix":"10.1016","volume":"138","author":[{"given":"Beata","family":"Donarska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrianna","family":"S\u0142awi\u0144ska-Brych","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Mizerska-Kowalska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Zdzisi\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech","family":"P\u0142azi\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof Z.","family":"\u0141\u0105czkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2023.106608_b0005","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.2174\/09298673113209990198","article-title":"Thalidomide-a notorious sedative to a wonder anticancer drug","volume":"20","author":"Zhou","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106608_b0010","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/cpt196563303","article-title":"Thalidomide in the treatment of lepra reactions","volume":"6","author":"Sheskin","year":"1965","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bioorg.2023.106608_b0015","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1084\/jem.177.6.1675","article-title":"Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation","volume":"177","author":"Moreira","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bioorg.2023.106608_b0020","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1084\/jem.187.11.1885","article-title":"Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset","volume":"187","author":"Haslett","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bioorg.2023.106608_b0025","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","article-title":"Thalidomide is an inhibitor of angiogenesis","volume":"91","author":"D'Amato","year":"1994","journal-title":"PNAS"},{"issue":"21","key":"10.1016\/j.bioorg.2023.106608_b0030","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM199911183412102","article-title":"Antitumor activity of thalidomide in refractory multiple myeloma","volume":"341","author":"Singhal","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2023.106608_b0035","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1200\/JCO.2003.03.139","article-title":"Thalidomide alone or with dexamethasone for previously untreated multiple myeloma","volume":"21","author":"Weber","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2023.106608_b0040","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.amjmed.2004.03.040","article-title":"Adverse effects of thalidomide administration in patients with neoplastic diseases","volume":"117","author":"Dimopoulos","year":"2004","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bioorg.2023.106608_b0045","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1053\/j.seminoncol.2005.06.018","article-title":"IMiDs: A novel class of immunomodulators","volume":"32","author":"Knight","year":"2005","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.bioorg.2023.106608_b0050","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1038\/leu.2012.119","article-title":"Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide","volume":"26","author":"Lopez-Girona","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.bioorg.2023.106608_b0055","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.3109\/10428194.2013.774393","article-title":"Lenalidomide versus thalidomide based regimens as first-line therapy for patients with multiple myeloma","volume":"10","author":"Zou","year":"2013","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.bioorg.2023.106608_b0060","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1586\/14737140.2014.906904","article-title":"Pomalidomide for the treatment of relapsed-refractory multiple myeloma: a review of biological and clinical data","volume":"14","author":"Offidani","year":"2014","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.bioorg.2023.106608_b0065","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/s41375-019-0620-8","article-title":"Iberdomide (CC-220) is a potent cereblon E3 ligase modulator with antitumor and immunostimulatory activities in lenalidomide- and pomalidomide-resistant multiple myeloma cells with dysregulated CRBN","volume":"34","author":"Bjorklund","year":"2020","journal-title":"Leukemia"},{"issue":"7611","key":"10.1016\/j.bioorg.2023.106608_b0070","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nature18611","article-title":"A novel cereblon modulator recruits GSPT1 to the CRL4(CRBN) ubiquitin ligase","volume":"535","author":"Matyskiela","year":"2016","journal-title":"Nature 535"},{"key":"10.1016\/j.bioorg.2023.106608_b0075","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.bmc.2003.11.007","article-title":"Thalidomide analogues demonstrate dual inhibition of both angiogenesis and prostate cancer","volume":"12","author":"Capitosti","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106608_b0080","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.biomag.2014.03.002","article-title":"Novel thalidomide analogs: anti-angiogenic and apoptotic effects on Hep-G2 and MCF-7 cancer cell lines","volume":"4","author":"Talaat","year":"2014","journal-title":"Biomed Aging Pathol"},{"key":"10.1016\/j.bioorg.2023.106608_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105302","article-title":"Thalidomide suppresses breast cancer tumor growth by inhibiting tumor-associated macrophage accumulation in breast tumor-bearing mice","volume":"151","author":"Wang","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2023.106608_b0090","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/ijms20010028","article-title":"Potent Anti-cancer properties of phthalimidebased curcumin derivatives on prostate tumor cells","volume":"20","author":"Belluti","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2023.106608_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102978","article-title":"Design and synthesis of new benzoxazole\/benzothiazole-phthalimide hybrids as antitumor-apoptotic agents","volume":"89","author":"Philoppes","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2023.106608_b0100","first-page":"101799","article-title":"Neutrophil elastase facilitates tumor cell intravasation and early metastatic events","volume":"23","author":"Deryugina","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2023.106608_b0105","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.3389\/fonc.2019.01146","article-title":"Tumor associated neutrophils. Their role in tumorigenesis, metastasis, prognosis and therapy","volume":"9","author":"Masucci","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.bioorg.2023.106608_b0110","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.3390\/ijms23063218","article-title":"Tumor-mediated neutrophil polarization and therapeutic implications","volume":"23","author":"Raftopoulou","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2023.106608_b0115","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.3390\/cancers13174495","article-title":"Neutrophil extracellular traps (NETs) in cancer invasion, evasion and metastasis","volume":"13","author":"Demkow","year":"2021","journal-title":"Cancer (Basel)"},{"key":"10.1016\/j.bioorg.2023.106608_b0120","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.biochi.2007.10.009","article-title":"Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physiopathological functions","volume":"90","author":"Korkmaz","year":"2008","journal-title":"Biochimie"},{"key":"10.1016\/j.bioorg.2023.106608_b0125","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.steroids.2017.11.006","article-title":"Neutrophil elastase in the tumor microenvironment","volume":"133","author":"Lerman","year":"2018","journal-title":"Steroids"},{"key":"10.1016\/j.bioorg.2023.106608_b0130","doi-asserted-by":"crossref","unstructured":"I. Lerman, M. Garcia-Hernandez, J. Rangel-Moreno, L. Chiriboga, Ch. Pan, K.L. Nastiuk, J.J. Krolewski, A. Sen, S.R. Hammes, Infiltrating myeloid cells exert pro-tumorigenic actions via neutrophil elastase, Mol. Cancer Res. 15 (2017) 1138\u20131152. https:\/\/doi.org\/10.1158\/1541-7786.MCR-17-0003.","DOI":"10.1158\/1541-7786.MCR-17-0003"},{"key":"10.1016\/j.bioorg.2023.106608_b0135","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.3892\/or.2017.5516","article-title":"Direct interaction between caffeic acid phenethyl ester and human neutrophil elastase inhibits the growth and migration of PANC-1 cells","volume":"37","author":"Duan","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bioorg.2023.106608_b0140","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.molonc.2012.03.005","article-title":"Curcumin inhibits tumor proliferation induced by neutrophil elastase through the upregulation of a1-antitrypsin in lung cancer","volume":"6","author":"Xu","year":"2012","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bioorg.2023.106608_b0145","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/1476-4598-12-154","article-title":"Promoting effect of neutrophils on lung tumorigenesis is mediated by CXCR2 and neutrophil elastase","volume":"12","author":"Gong","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioorg.2023.106608_b0150","first-page":"13","article-title":"Growth effect of neutrophil elastase on breast cancer: favourable action of sivelestat and application to anti-HER2 therapy","volume":"32","author":"Nawa","year":"2012","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bioorg.2023.106608_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175187","article-title":"Novel benzoxazinone derivative as potent human neutrophil elastase inhibitor: Potential implications in lung injury","volume":"931","author":"Sengupta","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2023.106608_b0160","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ddr.21323","article-title":"Synthesis and pharmacological evaluation of indole derivatives as deaza analogues of potent human neutrophil elastase inhibitors (HNE)","volume":"77","author":"Crocetti","year":"2016","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bioorg.2023.106608_b0165","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/glycob\/cww011","article-title":"N-Arylacyl O-sulfonated aminoglycosides as novel inhibitors of human neutrophil elastase, cathepsin G and proteinase 3","volume":"26","author":"Craciun","year":"2016","journal-title":"Glycobiology"},{"key":"10.1016\/j.bioorg.2023.106608_b0170","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bioorg.2019.01.040","article-title":"Synthesis and structure-activity relationship of elastase inhibiting novel ethylated thiazole-triazole acetamide hybrids: Mechanistic insights through kinetics and computational contemplations","volume":"86","author":"Butt","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2023.106608_b0175","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3390\/ijms24010110","article-title":"Spectrofluorimetric and computational investigation of new phthalimide derivatives towards human neutrophil elastase inhibition and antiproliferative activity","volume":"24","author":"Donarska","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2023.106608_b0180","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1021\/jm901082k","article-title":"4-Oxo-\u03b2-lactams (azetidine-2,4-diones) are potent and selective inhibitors of human leukocyte elastase","volume":"53","author":"Mulchande","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106608_b0185","doi-asserted-by":"crossref","first-page":"7566","DOI":"10.3390\/ijms23147566","article-title":"Discovery of new 3,3-diethylazetidine-2,4-dione based thiazoles as nanomolar human neutrophil elastase inhibitors with broad-spectrum antiproliferative activity","volume":"23","author":"Donarska","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2023.106608_b0190","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/14756366.2010.486794","article-title":"Synthesis, stability, biochemical and pharmacokinetic properties of a new potent and selective 4-oxo-\u03b2-lactam inhibitor of human leukocyte elastase","volume":"26","author":"Mulchande","year":"2011","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106608_b0195","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1002\/cmdc.201600258","article-title":"Clickable 4-oxo-\u03b2-lactam-based selective probing for human neutrophil elastase related proteomes","volume":"11","author":"Ruivo","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2023.106608_b0200","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.2169\/internalmedicine.49.4010","article-title":"Effect of neutrophil elastase inhibitor (sivelestat sodium) in the treatment of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): a systematic review and meta-analysis","volume":"49","author":"Iwata","year":"2010","journal-title":"Intern. Med."},{"key":"10.1016\/j.bioorg.2023.106608_b0205","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.tetlet.2017.12.049","article-title":"Excited-state intramolecular proton transfer (ESIPT) fluorescence from 3-amidophthalimides displaying RGBY emission in the solid state","volume":"59","author":"Okamoto","year":"2018","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.bioorg.2023.106608_b0210","doi-asserted-by":"crossref","unstructured":"L. Zhang, R. Chen, X. Li, X. Xu, Z. Xu, J. Cheng, Y. Wang, Y. Li, X. Shao, Z. Li, Synthesis, insecticidal activities, and 3D-QASR of N-pyridylpyrazole amide derivatives containing a phthalimide as potential ryanodine receptor activators. J. Agric. Food Chem. 70 (2022) 12651\u201312662. https:\/\/doi.org\/10.1021\/acs.jafc.2c03971.","DOI":"10.1021\/acs.jafc.2c03971"},{"key":"10.1016\/j.bioorg.2023.106608_b0215","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1055\/s-0040-1720460","article-title":"Thionation of aminophthalimide hindered carbonyl groups and application to the synthesis of 3,6\u2032-dithionated pomalidomides","volume":"32","author":"Scerba","year":"2021","journal-title":"Synlett"},{"key":"10.1016\/j.bioorg.2023.106608_b0220","doi-asserted-by":"crossref","first-page":"4460","DOI":"10.1016\/j.bmc.2011.06.036","article-title":"Design, synthesis and evaluation of N-benzoylindazole derivatives and analogues as inhibitors of human neutrophil elastase","volume":"19","author":"Crocetti","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2023.106608_b0225","doi-asserted-by":"crossref","first-page":"9050","DOI":"10.3390\/ijms21239050","article-title":"Tropinone-derived alkaloids as potent anticancer agents: synthesis, tyrosinase inhibition, mechanism of action, DFT calculation, and molecular docking studies","volume":"21","author":"Piechowska","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2023.106608_b0230","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1758-2946-4-17","article-title":"Avogadro: An advanced semantic chemical editor, visualization, and analysis platform","volume":"4","author":"Hanwell","year":"2012","journal-title":"J Cheminformatics"},{"key":"10.1016\/j.bioorg.2023.106608_b0235","doi-asserted-by":"crossref","first-page":"10024","DOI":"10.1021\/ja00051a040","article-title":"UFF, a full periodic table force field for molecular mechanics and dynamics simulations","volume":"114","author":"Rappe","year":"1992","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2023.106608_b0240","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bioorg.2023.106608_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104819","article-title":"Effect of the dichloro-substitution on antiproliferative activity of phthalimide-thiazole derivatives. Rational design, synthesis, elastase, caspase 3\/7, and EGFR tyrosine kinase activity and molecular modeling study","volume":"110","author":"Donarska","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2023.106608_b0250","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3390\/pharmaceutics12040358","article-title":"Novel and modified neutrophil elastase inhibitor loaded in topical formulations for psoriasis management","volume":"12","author":"Nunes","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioorg.2023.106608_b0255","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ijbiomac.2012.04.023","article-title":"Direct interaction of ONO-5046 with human neutrophil elastase through 1H NMR and molecular docking","volume":"51","author":"Feng","year":"2012","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2023.106608_b0260","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3389\/fchem.2020.00795","article-title":"Novel sulfonamide analogs of sivelestat as potent human neutrophil elastase inhibitors","volume":"8","author":"Crocetti","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.bioorg.2023.106608_b0265","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.1080\/07391102.2021.1873189","article-title":"Molecular elucidation of pancreatic elastase inhibition by baicalein","volume":"40","author":"Ghosh","year":"2022","journal-title":"J. Biomol. Struct. Dyn."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823002699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823002699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:46:28Z","timestamp":1758617188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206823002699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":53,"alternative-id":["S0045206823002699"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106608","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thalidomide derivatives as nanomolar human neutrophil elastase inhibitors: Rational design, synthesis, antiproliferative activity and mechanism of action","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106608","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106608"}}